Starting Regimen Predicts Early ADHD Treatment Instability in Adults
This large Japanese claims analysis quantifies how the initial ADHD drug choice associates with early regimen modification, informing counseling on persistence expectations.
ADHD treatment choice influences medication stability in Japanese adults.
Understanding medication regimen changes in adults with attention-deficit/hyperactivity disorder (ADHD) can help improve treatment strategies and adherence. The study found that initial polytherapy had a higher instability rate compared to methylphenidate alone, with a subdistribution hazard ratio of 2.65. The findings highlight significant differences in regimen stability among ADHD treatments, indicating the need for careful selection and monitoring of therapy in practice. Initial ADHD medication choice affects treatment stability, with polytherapy showing higher instability.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Citation:Yonezawa N, Momo K Real-World Medication Regimen Change in Adults with ADHD: A Large Claims Database Study. Biological & pharmaceutical bulletin. 2026;49(8):1263-1270. doi:10.1248/bpb.b26-00127
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Want the full analysis?
Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.